ACKNOWLEDGEMENT

We've been performing corneal cross-linking with UV-A / riboflavin (CXL) in keratoconus, pellucid marginal degeneration and post-LASIK ectasia since 2008. And today, the number of CXL we performed have just reached to 700 patients. We'd like to thank all of our patients for their trust and loyalty.

Sincerely yours,

Koray Gumus, MD, FEBOphth